Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
11m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
38m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
38m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Emergent Biosolutions Inc logo

Emergent Biosolutions Inc

About

Emergent Biosolutions Inc (NYSE:EBS) — investor relations, events, news, and company updates on 6ix.

Latest News

Today
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
Apr 16 2026
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
Apr 9 2026
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
Apr 7 2026
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
Apr 2 2026
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences

Financials

Revenue
$742.9 M
Market Cap
$426.07 M
P/E Ratio
8.85
EPS
0.93

Community Chat

Ask AI

6ix6ixAIEvents